KALA BIO, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
KALA BIO, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2016 to Q4 2023.
  • KALA BIO, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $129M, a 6.03% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $129M +$7.33M +6.03% Dec 31, 2023 10-K 2024-03-29
Q4 2022 $121M -$2.73M -2.2% Dec 31, 2022 10-K 2024-03-29
Q4 2021 $124M +$36.6M +41.8% Dec 31, 2021 10-K 2023-03-03
Q4 2020 $87.6M +$17.5M +25% Dec 31, 2020 10-K 2022-03-29
Q4 2019 $70.1M +$13.5M +23.8% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $56.6M +$16.4M +40.8% Dec 31, 2018 10-K 2020-02-12
Q4 2017 $40.2M -$861K -2.1% Dec 31, 2017 10-K 2019-03-12
Q4 2016 $41M Dec 31, 2016 10-K 2018-04-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.